Hot Take Debate: Was Mr. Beast's Cataract Surgery Video charitable?











Adam Faircloth joins the debate. 
https://www.linkedin.com/in/adamfaircloth/ 
 
Context:  MR Beast made content around paying for 1k eye surgeries, is this charitable.  the video has 95million views and was sponsored by Experian.


At a rate of $2.13 per CPM, the video has generated at least $200k. 
 






















does it matter that it isn't a nonprofit?






















what if it was a nonprofit?






















how does this compare to flies in the eyes videos of african children that used to be used for fundraising






















does it matter if Mr Beast made a profit on this?






















what difference is there between actors being paid to perform in a video and people getting their surgeries covered to perform in a video






















Is this actually a potential earned revenue model?
 
 
Other NonprofitNewsfeed.com Summary

World Cancer Day Promotes Advocacy, Awareness, & Early Detection
World Cancer Day, which was this past Saturday, emphasizes the importance of awareness around cancer, its potential symptoms, and the importance of an early diagnosis. The BBC acknowledged the day of advocacy by highlighting stories of young cancer patients who were misdiagnosed, acknowledging that young people can get cancer too. Many nonprofits, including Whole Whale client LCFA, advocates for research, awareness, and community on behalf of those impacted by cancers of various type. Many hospitals and other medical centers launched advocacy campaigns themselves, including the Georgia Cancer Center.
➝
 
Late Subway Cofounder Donates 50 Percent Ownership to Nonprofit  | QSR magazine
Local nonprofit cleans up 36,000 pounds of trash along American River  |  CBS News
World’s biggest YouTuber paid for 1,000 people to get eye surgery but is slammed for ‘making content out of people who can’t see’   |  Fortune
Gorillas, militias, and Bitcoin: Why Congo’s most famous national park is betting big on crypto  |  MIT Technology Review
 


 
 
 
 

Ver todos los episodios